Elegent Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1990.

1990 Mumbai, Maharashtra, India Active

Last Updated: December 19, 2025

About Elegent Pharmaceuticals Limited

Elegent Pharmaceuticals Limited, a active public limited company, was established on 11 July 1990 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: L24239MH1990PLC057214. Registered under ROC Roc Mumbai. it is listed. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹4.39 Cr.

It upholds a active non-compliant status. Its leadership includes Manjula Bhanulal Sanghavi (Additional Director), Tejas Baiju Desai (Additional Director), Dhirendra Bhanulal Sanghavi (Managing Director). Past directors included Bharat Hargovind Shah, Pareshkumar Chandulal Shah. It holds ₹20.51 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Room No. 9, Irani Chawl, New Prabhadevi, Prabhadevi Temple, Veer Savarkar Road,, Mumbai, Maharashtra, 400025.

Company Details

CIN/LLPIN
L24239MH1990PLC057214
Registration Number
057214
Incorporation Date
11 July 1990
Authorized Capital
₹10.00 Cr
Paid-Up Capital
₹4.39 Cr
ROC Code
Roc Mumbai
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 10.00 Cr as on 19-12-2025
Paid Up Capital ₹ 4.39 Cr as on 19-12-2025
Company Age 35 Year, 7 Months
Last Filing with ROC 31 Mar 2016
Open Charges ₹ 20.51 Cr as on 19-12-2025
Revenue Growth **** % (FY 2016)
Ebitda ****
Net Worth -0.00% (FY 2016)
Total Assets **** % (FY 2016)

Comprehensive Company Insights

Explore comprehensive insights into Elegent Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Elegent Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Manjula Bhanulal Sanghavi	Additional Director	29 Nov 2018	Current
Tejas Baiju Desai	Additional Director	29 Nov 2018	Current
Dhirendra Bhanulal Sanghavi	Managing Director	23 Mar 1992	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	29 Nov 2018	Past
Pramod Abcsdd	Director	29 Nov 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elegent Pharmaceuticals.

Elegent Pharmaceuticals Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of -0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

-0.00%

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elegent Pharmaceuticals?

Unlock access to Elegent Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹205,139,200.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Bank Of Baroda : 19.21 Cr
Union Bank Of India : 1.30 Cr

Latest Charge Details

Date	Lender	Amount	Status
09 Feb 1996	Union Bank Of India	₹5.00 M	Open
30 Jun 1995	Bank Of Baroda	₹1.50 Cr	Open
25 Feb 1995	Bank Of Baroda	₹5.00 M	Open
24 Oct 1994	Union Bank Of India	₹8.00 M	Open
12 Oct 1994	Bank Of Baroda	₹5.26 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Elegent Pharmaceuticals?

Unlock and access historical data on people associated with Elegent Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Elegent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elegent Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elegent Pharmaceuticals

Recent Activity within the Organization

Director Appointment

The activity Manjula Bhanulal Sanghavi was appointed as a Additional Director was appointed as a Additional Director on 29 Nov 2018 & has been associated with this company since 7 years 2 months . was completed.
29 Nov 2018
Director Appointment

The activity Tejas Baiju Desai was appointed as a Additional Director was appointed as a Additional Director on 29 Nov 2018 & has been associated with this company since 7 years 2 months . was completed.
29 Nov 2018
Annual General Meeting

Elegent Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was recorded as a recent event.
30 Sep 2016
Balance Sheet

Progress on Elegent Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was documented.
31 Mar 2016
Charges

The activity A charge with Bank Of Baroda of Rs. 0.50 Cr registered on 25 Feb 1995 with Charge ID 90352324 was modified on 31 Jan 2008. was completed.
31 Jan 2008
Charges

Progress on A charge with Bank Of Baroda of Rs. 5.26 Cr registered on 12 Oct 1994 with Charge ID 90352292 was modified on 31 Jan 2008. was documented.
31 Jan 2008

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Elegent Pharmaceuticals Limited?

The CIN of Elegent Pharmaceuticals Limited is L24239MH1990PLC057214.

Where is Elegent Pharmaceuticals Limited headquartered?

Elegent Pharmaceuticals Limited is headquartered at Room No. 9, Irani Chawl, New Prabhadevi, Prabhadevi Temple, Veer Savarkar Road,, Mumbai, Maharashtra, 400025.

When was Elegent Pharmaceuticals Limited incorporated?

Elegent Pharmaceuticals Limited was incorporated on 11 July 1990.

Who are the current directors of Elegent Pharmaceuticals Limited?

The current directors of Elegent Pharmaceuticals Limited are

What is the primary industry of Elegent Pharmaceuticals Limited?

The primary industry of Elegent Pharmaceuticals Limited is Pharma.

Is Elegent Pharmaceuticals Limited a listed company?

Elegent Pharmaceuticals Limited is listed.

What is the capital structure of Elegent Pharmaceuticals Limited?

The authorized capital of Elegent Pharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹4.39 Cr.

What is the compliance status of Elegent Pharmaceuticals Limited?

The compliance status of Elegent Pharmaceuticals Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available